| Literature DB >> 31595875 |
Elisabeth M den Boogert1, Danielle M Oorsprong1, Ewout B Fanoy2,3, Alexander Cap Leenders4, Alma Tostmann5, Adriana Sg van Dam1.
Abstract
BackgroundIn the Netherlands, obstacle, mud and survival runs are increasingly popular. Although outbreaks of gastroenteritis have been reported following these events, associated health risks have not been systematically assessed.AimTo investigate the incidence of acute gastrointestinal infections (AGI), skin infections (SI) and respiratory infections (RI) among obstacle run participants, as well as risk factors.MethodsBetween April and October 2017, we conducted a retrospective cohort study among 2,900 participants of 17 obstacle runs in the Netherlands. Demographic, symptomatic and behavioural data were collected from participants via an online questionnaire 1 week after participation in an obstacle run. Stool specimens were obtained from respondents for microbiological tests. Adjusted relative risks (aRR) and 95% confidence intervals (CI) using multilevel binomial regression analysis were calculated.ResultsOf 2,646 respondents (median age: 33 years; 53% male), 76 had AGI after the obstacle run; ingesting mud was associated with AGI (aRR: 1.7; 95% CI: 1.2-4.9) and 38 respondents had AGI during or in the week before the obstacle run. Overall, 103 respondents reported SI and 163 RI. Rinsing off in a hot tub was associated with SI (aRR: 2.2; 95% CI: 1.7-2.8). Of 111 stool specimens, 13 tested positive for six different pathogens. No clusters were found.ConclusionThe reported incidence of AGI, SI and RI was low. Risk of these infections could be decreased by informing participants on preventive measures, e.g. showering vs rinsing in the hot tub, avoiding ingesting mud and not participating with symptoms of AGI.Entities:
Keywords: epidemiology; gastrointestinal disease; hygiene; infection control; mass gatherings; respiratory infections
Year: 2019 PMID: 31595875 PMCID: PMC6784448 DOI: 10.2807/1560-7917.ES.2019.24.40.1900088
Source DB: PubMed Journal: Euro Surveill ISSN: 1025-496X
Characteristics of respondents from 17 obstacle runs, the Netherlands, 2017 (n = 2,900)
| Characteristics | n | % |
|---|---|---|
|
|
|
|
| Male | 1,435 | 53.3 |
| Female | 1,258 | 46.7 |
| Missing | 207 | NA |
|
|
|
|
| < 18 | 311 | 11.6 |
| 19–25 | 363 | 13.5 |
| 26–35 | 863 | 32.1 |
| 36–45 | 784 | 29.1 |
| > 45 | 371 | 13.8 |
| Missing | 208 | NA |
|
| ||
|
|
|
|
| Yes | 76 | 2.7 |
| No | 2,732 | 97.3 |
| Missing | 92 | NA |
|
|
|
|
| Yes | 103 | 3.7 |
| No | 2,687 | 96.3 |
| Missing | 110 | NA |
|
|
|
|
| Yes | 163 | 5.8 |
| No | 2,627 | 94.2 |
| Missing | 110 | NA |
|
|
|
|
| Yes | 185 | 6.9 |
| No | 2,506 | 93.1 |
| Missing | 209 | NA |
|
|
|
|
| Yes | 216 | 8.1 |
| No | 2,442 | 91.9 |
| Missing | 242 | NA |
|
|
|
|
| Yes | 449 | 16.9 |
| No | 2,209 | 83.1 |
| Missing | 242 | NA |
|
|
|
|
| Yes | 411 | 15.5 |
| No | 2,247 | 84.5 |
| Missing | 242 | NA |
|
|
|
|
| Yes | 1,080 | 37.7 |
| No | 1,784 | 62.3 |
| Missing | 36 | NA |
NA: not applicable.
a For example, antibiotics or antacids.
b For example, hay fever or other self-defined allergies.
c Other than allergies; for example, diabetes, immune disorders or gastrointestinal diseases.
Additional information on the questions asked in the questionnaire can be found in Supplement S1.
Characteristics of the obstacle runs, the Netherlands, 2017 (n = 17)
| Characteristics | n |
|---|---|
|
| |
| < 1,000 | 9 |
| ≥ 1,000 | 8 |
|
| |
| 1 | 10 |
| 2 | 7 |
|
| |
| Heavy rain | 0 |
| Light rain | 4 |
| No rain | 13 |
|
| |
| < 15.0 | 0 |
| 15.1–20.0 | 7 |
| 20.1–25.0 | 6 |
| > 25.1 | 4 |
|
| |
| Only official | 2 |
| Only non-official | 12 |
| Both official and non-officiala | 3 |
|
| |
| Running water | 11 |
| Paper towels | 4 |
| Soap | 4 |
| Rinse facilitiesb | 16 |
|
| |
| Food | 14 |
| Fruit without peelc | 6 |
| Free drinking water | 17 |
| Animal faeces present on trail | 7 |
a Official swimming water was officially approved for swimming by local authorities and non-official swimming water was not checked by local authorities.
b For example, shower, garden hose or cold water tub.
c In 13 obstacle runs.
d Depending on the obstacle run this was either bottled water or tap water.
Additional information on the questions asked in the questionnaire can be found in Supplement S1.
Determinants for developing acute gastrointestinal infections in obstacle run participants, the Netherlands, 2017 (n = 2,808)
| Variables | Total | Cases of AGIb | Attack rate (%) | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|---|---|---|
| RR | p value | RR | p value | ||||
|
| |||||||
|
| |||||||
| 0–18 | 311 | 6 | 1.9 | 0.69 (0.22–2.2) | 0.530 | 0.63 (0.21–1.9) | 0.412 |
| 19–25 | 363 | 15 | 4.1 | 1.5 (0.71–3.1) | 0.293 | 1.2 (0.55–2.6) | 0.661 |
| 26–35 | 863 | 24 | 2.8 | Ref | Ref | ||
| 36–45 | 784 | 22 | 2.8 | 1.01 (0.64–1.6) | 0.969 | 1.01 (0.59–1.7) | 0.964 |
| > 45 | 371 | 2 | 0.54 | 0.19 (0.04–0.87) |
| 0.23 (0.05–1.1) | 0.067 |
|
| |||||||
| Male | 1,435 | 22 | 1.5 | Ref | Ref | ||
| Female | 1,258 | 47 | 3.7 | 2.4 (1.8–3.3) |
| 1.9 (1.2–2.8) |
|
|
| |||||||
| No | 2,506 | 65 | 2.6 | Ref | NA | ||
| Yes | 185 | 4 | 2.2 | 0.8 (0.35–2.0) | 0.681 | NA | |
|
| |||||||
| No | 1,746 | 56 | 3.2 | Ref | Ref | ||
| Yes | 1,062 | 20 | 1.9 | 0.59 (0.40–0.86) |
| 0.71 (0.47–1.1) | 0.118 |
|
| |||||||
| No | 2,442 | 62 | 2.5 | Ref | NA | ||
| Yes | 216 | 6 | 2.8 | 1.09 (0.45–2.7) | 0.843 | NA | |
|
| |||||||
| No | 2,637 | 67 | 2.5 | Ref | NA | ||
| Yes | 21 | 1 | 4.8 | 1.9 (0.37–9.4) | 0.444 | NA | |
|
| |||||||
| No | 2,209 | 49 | 2.2 | Ref | Ref | ||
| Yes | 449 | 19 | 4.2 | 1.9 (1.3–2.8) |
| 1.7 (1.2–2.5) |
|
|
| |||||||
| No | 2,247 | 61 | 2.7 | Ref | Ref | ||
| Yes | 411 | 7 | 1.7 | 0.63 (0.43–0.91) |
| 0.51 (0.33–0.79) |
|
|
| |||||||
|
| |||||||
| 0–4.9 | 190 | 3 | 1.6 | 0.54 (0.11–2.6) | 0.446 | NA | |
| 5–7.9 | 1,093 | 32 | 2.9 | Ref | NA | ||
| 8–10 | 469 | 12 | 2.6 | 0.87 (0.38–2.0) | 0.750 | NA | |
| 10.1–15 | 786 | 21 | 2.7 | 0.91 (0.44–1.9) | 0.808 | NA | |
| > 15.1 | 270 | 8 | 3.0 | 1.01 (0.48–2.2) | 0.975 | NA | |
|
| |||||||
| ≤ 15.0 | 0 | 0 | NA | NA | NA | ||
| 15.1–20.0 | 1,149 | 40 | 3.5 | Ref | NA | ||
| 20.1–25.0 | 802 | 17 | 2.1 | 0.61 (0.26–1.4) | 0.255 | NA | |
| ≥ 25.1 °C | 857 | 19 | 2.2 | 0.64 (0.30–1.4) | 0.245 | NA | |
|
| |||||||
| Non-official | 1,945 | 50 | 2.6 | Ref | NA | ||
| Official | 411 | 11 | 2.7 | 1.04 (0.49–2.2) | 0.918 | NA | |
| Both | 452 | 15 | 3.3 | 1.3 (0.70–2.4) | 0.419 | NA | |
|
| |||||||
| 1 | 1,201 | 22 | 1.8 | Ref | NA | ||
| 2 | 1,607 | 54 | 3.4 | 1.8 (0.97–3.5) | 0.064 | NA | |
|
| |||||||
| No | 1,856 | 58 | 3.1 | Ref | NA | ||
| Yes | 952 | 18 | 1.9 | 0.61 (0.32–1.1) | 0.122 | NA | |
|
| |||||||
|
| |||||||
| Tap water | 2,364 | 59 | 2.5 | Ref | NA | ||
| Open water | 236 | 7 | 3.0 | 1.2 (0.65–2.2) | 0.573 | NA | |
| Hot tub | 80 | 2 | 2.5 | 1.002 (0.43–2.4) | 0.997 | NA | |
| Other | 35 | 1 | 2.9 | 1.1 (0.37–3.5) | 0.813 | NA | |
|
| |||||||
| < 1 | 1,840 | 52 | 2.8 | Ref | NA | ||
| 1–3 | 706 | 15 | 2.1 | 0.75 (0.43–1.3) | 0.313 | NA | |
| > 3 | 174 | 2 | 1.2 | 0.41 (0.17–0.95) |
| NA | |
|
| |||||||
| No | 862 | 18 | 2.1 | Ref | NA | ||
| Yes | 1,856 | 51 | 2.8 | 1.3 (0.80–2.2) | 0.276 | NA | |
|
| |||||||
| No | 1,092 | 16 | 1.5 | Ref | Ref | ||
| Yes, not swallowed | 1,200 | 35 | 2.9 | 2.0 (1.1–3.8) |
| 2.0 (0.94–4.1) | 0.071 |
| Yes, swallowed | 440 | 19 | 4.3 | 2.9 (1.4–6.2) |
| 2.2 (0.97–5.2) | 0.061 |
|
| |||||||
| No | 1,762 | 39 | 2.2 | Ref | Ref | ||
| Yes, not swallowed | 882 | 24 | 2.7 | 1.2 (0.8–1.9) | 0.350 | 1.02 (0.61–1.7) | 0.946 |
| Yes, swallowed | 85 | 7 | 8.2 | 3.7 (1.8–7.7) |
| 2.4 (1.2–4.9) |
|
|
| |||||||
|
| |||||||
| No | 459 | 7 | 1.5 | Ref | NA | ||
| Yes | 2,229 | 62 | 2.8 | 1.8 (0.79–4.2) | 0.162 | NA | |
|
| |||||||
| No | 2,130 | 60 | 2.8 | Ref | NA | ||
| Yes | 558 | 9 | 1.6 | 0.57 (0.29–1.1) | 0.105 | NA | |
|
| |||||||
| No | 2,165 | 53 | 2.5 | Ref | NA | ||
| Yes | 523 | 16 | 3.1 | 1.2 (0.73–2.1) | 0.419 | NA | |
|
| |||||||
| No | 2,031 | 62 | 3.1 | Ref | Ref | ||
| Yes | 657 | 7 | 1.1 | 0.35 (0.18–0.67) |
| 0.34 (0.16–0.71) |
|
|
| |||||||
| No | 2,196 | 55 | 2.5 | Ref | NA | ||
| Yes | 492 | 14 | 2.9 | 1.1 (0.62–2.1) | 0.682 | NA | |
|
| |||||||
| No | 1,791 | 39 | 2.2 | Ref | NA | ||
| Yes | 58 | 2 | 3.5 | 1.6 (0.27–9.4) | 0.613 | NA | |
AGI: acute gastrointestinal infections; CI: confidence interval; incl.: including; NA: not applicable; Ref: reference; RR: relative risk.
a Number of respondents who were exposed to the exposure variable.
b Number of respondents with gastrointestinal infections in the week after the event and exposure to the exposure variable.
c Adjusted for any exposure with p value < 0.05 in the univariable analysis.
d For example, antibiotics or antacids.
e For example, hay fever or other self-defined allergies.
f Other than allergies; for example, diabetes, immune disorders and gastrointestinal diseases.
g Official swimming water was officially approved for swimming by local authorities and non-official swimming water was not checked by local authorities.
Additional information on the questions asked in the questionnaire can be found in Supplement S1.
The questions on diarrhoea and vomiting were asked later on in the questionnaire and some respondents stopped before answering these questions. Only responses from those who answered these questions were included.
Determinants for developing skin infections in obstacle run participants, the Netherlands, 2017 (n = 2,790)
| Variables | Total | Cases of SIb | Attack rate | Univariable | Multivariable | ||
|---|---|---|---|---|---|---|---|
| RR | p value | RR | p value | ||||
|
| |||||||
|
| |||||||
| 0–18 | 311 | 11 | 3.5 | 0.92 (0.48–1.8) | 0.819 | 1.2 (0.58–2.5) | 0.607 |
| 19–25 | 363 | 21 | 5.8 | 1.5 (0.94–2.4) | 0.089 | 1.4 (0.84–2.3) | 0.202 |
| 26–35 | 863 | 33 | 3.8 | Ref | Ref | ||
| 36–45 | 784 | 25 | 3.2 | 0.83 (0.46–1.5) | 0.555 | 0.92 (0.50–1.7) | 0.797 |
| > 45 | 371 | 9 | 2.4 | 0.63 (0.38–1.1) | 0.081 | 0.76 (0.42–1.4) | 0.360 |
|
| |||||||
| Male | 1,435 | 31 | 2.2 | Ref | Ref | ||
| Female | 1,258 | 68 | 5.4 | 2.5 (1.4–4.6) |
| 2.3 (1.3–3.9) |
|
|
| |||||||
| No | 1,733 | 73 | 4.2 | Ref | NA | ||
| Yes | 1,057 | 30 | 2.8 | 0.67 (0.39–1.2) | 0.166 | NA | |
|
| |||||||
| No | 2,209 | 76 | 3.4 | Ref | NA | ||
| Yes | 449 | 22 | 4.9 | 1.4 (0.95–2.1) | 0.087 | NA | |
|
| |||||||
| No | 2,247 | 74 | 3.3 | Ref | Ref | ||
| Yes | 411 | 24 | 5.8 | 1.8 (1.03–3.1) |
| 1.7 (0.97–2.8) | 0.065 |
|
| |||||||
|
| |||||||
| ≤ 15.0 | 0 | 0 | NA | NA | NA | ||
| 15.1–20.0 | 1,137 | 62 | 5.5 | Ref | Ref | ||
| 20.1–25.0 | 80 | 20 | 2.5 | 0.46 (0.23–0.89) |
| 0.56 (0.31–1.005) | 0.052 |
| ≥ 25.1 °C | 853 | 21 | 2.5 | 0.45 (0.23–0.90) |
| 0.53 (0.31–0.91) |
|
|
| |||||||
| 1 | 1,193 | 54 | 4.5 | Ref | NA | ||
| 2 | 1,597 | 49 | 3.1 | 0.68 (0.30–1.5) | 0.341 | NA | |
|
| |||||||
| No | 1,841 | 61 | 3.3 | Ref | NA | ||
| Yes | 949 | 42 | 4.4 | 1.3 (0.64–2.8) | 0.436 | NA | |
|
| |||||||
|
| |||||||
| Tap water | 2,364 | 76 | 3.2 | Ref | Ref | ||
| Open water | 236 | 16 | 6.8 | 2.1 (0.80–5.6) | 0.133 | 1.5 (0.67–3.4) | 0.319 |
| Hot tub | 80 | 6 | 7.5 | 2.3 (1.6–3.4) |
| 2.2 (1.7–2.8) |
|
| Other | 35 | 1 | 2.9 | 0.89 (0.10–8.1) | 0.916 | 0.66 (0.08–5.4) | 0.696 |
|
| |||||||
| < 1 | 1,840 | 61 | 3.3 | Ref | NA | ||
| 1–3 | 706 | 32 | 4.5 | 1.4 (0.96–2.0) | 0.086 | NA | |
| > 3 | 174 | 6 | 3.5 | 1.04 (0.50–2.1) | 0.915 | NA | |
|
| |||||||
| Long pants, long sleeves | 333 | 14 | 4.2 | Ref | NA | ||
| Long pants, short sleeves/short pants, long sleeves combined | 1,420 | 52 | 3.7 | 0.87 (0.49–1.6) | 0.642 | NA | |
| Short pants, short sleeves | 889 | 30 | 3.4 | 0.80 (0.35–1.8) | 0.603 | NA | |
| Other | 78 | 3 | 3.9 | 0.91 (0.29–2.9) | 0.880 | NA | |
CI: confidence interval; NA: not applicable; Ref: reference; RR: relative risk; SI: skin infections.
a Number of respondents who were exposed to the exposure variable.
b Number of respondents with skin infections in the week after the event and exposure to the exposure variable.
c Adjusted for any exposure with p value < 0.05 in the univariable analysis.
d For example, hay fever or other self-defined allergies.
e Other than allergies; for example, diabetes, immune disorders and gastrointestinal diseases.
Additional information on the questions asked in the questionnaire can be found in Supplement S1.
The question on skin infections was asked later on in the questionnaire and some respondents stopped before answering this question. Only responses from those who answered this question were included.
Determinants for developing respiratory infections in obstacle run participants, the Netherlands, 2017 (n = 2,790)
| Variables | Total | Cases of RIb | Attack rate | Univariable | Multivariable | ||
|---|---|---|---|---|---|---|---|
| RR | p value | RR | p value | ||||
|
| |||||||
|
| |||||||
| 0–18 | 311 | 20 | 6.4 | 1.2 (0.88–1.7) | 0.245 | 1.4 (0.98–2.0) | 0.061 |
| 19–25 | 363 | 38 | 10 | 2.0 (1.2–3.1) |
| 1.8 (1.2–2.9) |
|
| 26–35 | 863 | 46 | 5.3 | Ref | Ref | ||
| 36–45 | 784 | 41 | 5.2 | 0.98 (0.59–1.6) | 0.941 | 1.1 (0.64–1.7) | 0.842 |
| > 45 | 371 | 5 | 1.4 | 0.25 (0.13–0.48) |
| 0.31 (0.16–0.60) |
|
|
| |||||||
| Male | 1,435 | 47 | 3.3 | Ref | Ref | ||
| Female | 1,258 | 103 | 8.2 | 2.5 (1.9–3.4) |
| 2.1 (1.6–3.0) |
|
|
| |||||||
| No | 2,506 | 135 | 5.4 | Ref | NA | ||
| Yes | 185 | 15 | 8.1 | 1.5 (0.92–2.5) | 0.107 | NA | |
|
| |||||||
| No | 1733 | 109 | 6.3 | Ref | NA | ||
| Yes | 1057 | 54 | 5.1 | 0.81 (0.56–1.2) | 0.268 | NA | |
|
| |||||||
| No | 2,442 | 137 | 5.6 | Ref | NA | ||
| Yes | 216 | 11 | 5.1 | 0.91 (0.52–1.6) | 0.733 | NA | |
|
| |||||||
| No | 2,604 | 142 | 5.5 | Ref | NA | ||
| Yes | 54 | 6 | 11 | 2.0 (0.90–4.6) | 0.087 | NA | |
|
| |||||||
| No | 2,611 | 145 | 5.6 | Ref | NA | ||
| Yes | 47 | 3 | 6.4 | 1.1 (0.42–3.1) | 0.784 | NA | |
|
| |||||||
| No | 2,209 | 109 | 4.9 | Ref | Ref | ||
| Yes | 449 | 39 | 8.7 | 1.8 (1.1–2.8) |
| 1.6 (0.99–2.6) | 0.054 |
|
| |||||||
| No | 2,247 | 116 | 5.2 | Ref | NA | ||
| Yes | 411 | 32 | 7.8 | 1.5 (0.99–2.3) | 0.054 | NA | |
|
| |||||||
|
| |||||||
| ≤ 15.0 | 0 | 0 | NA | NA | NA | ||
| 15.1–20.0 | 1,137 | 78 | 6.9 | Ref | NA | ||
| 20.1–25.0 | 800 | 50 | 6.3 | 0.91 (0.60–1.4) | 0.667 | NA | |
| ≥ 25.1 | 853 | 35 | 4.1 | 0.60 (0.26–1.4) | 0.235 | NA | |
|
| |||||||
| Heavy rain | 0 | 0 | NA | NA | NA | ||
| Light rain | 663 | 41 | 6.2 | Ref | NA | ||
| No rain | 2,127 | 122 | 5.7 | 0.93 (0.58–1.5) | 0.750 | NA | |
|
| |||||||
| 1 | 1,193 | 77 | 6.5 | Ref | NA | ||
| 2 | 1,597 | 86 | 5.4 | 0.83 (0.51–1.4) | 0.462 | NA | |
|
| |||||||
|
| |||||||
| Tap water | 2,364 | 129 | 5.5 | Ref | Ref | ||
| Open water | 236 | 18 | 7.6 | 1.4 (1.1–1.8) |
| 1.3 (0.84–2.0) | 0.246 |
| Hot tub | 80 | 4 | 5.0 | 0.92 (0.54–1.6) | 0.749 | 1.2 (0.64–2.1) | 0.626 |
| Other | 35 | 1 | 2.9 | 0.52 (0.05–5.2) | 0.579 | 0.51 (0.06–4.3) | 0.536 |
|
| |||||||
| No | 1,092 | 53 | 4.9 | Ref | NA | ||
| Yes, not swallowed | 1,200 | 75 | 6.3 | 1.3 (0.84–2.0) | 0.240 | NA | |
| Yes, swallowed | 440 | 25 | 5.7 | 1.2 (0.78–1.8) | 0.451 | NA | |
|
| |||||||
| No | 1,762 | 96 | 5.5 | Ref | NA | ||
| Yes, not swallowed | 882 | 52 | 5.9 | 1.1 (0.74–1.6) | 0.683 | NA | |
| Yes, swallowed | 85 | 5 | 5.9 | 1.1 (0.45–2.6) | 0.863 | NA | |
CI: confidence interval; incl.: including; NA: not applicable; Ref: reference; RI: respiratory infections; RR: relative risk.
a Number of respondents who were exposed to the exposure variable.
b Number of respondents with respiratory infections in the week after the event and exposure to the exposure variable.
c Adjusted for any exposure with p value < 0.05 in the univariable analysis.
d For example, antibiotics or antacids.
e For example, hay fever or other self-defined allergies.
f Other than allergies; for example, diabetes, immune disorders or gastrointestinal diseases.
Additional information on the questions asked in the questionnaire can be found in Supplement S1.
The question on respiratory infections was asked later on in the questionnaire and some respondents stopped before answering this question. Only responses from those who answered this question were included.